Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

NCT ID: NCT06680674

Last Updated: 2025-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-13

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.

However, the pharmacological treatment of diabesity has made significant progress in recent years.

The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. to determine the prevalence of causes and duration of hospitalization
2. to investigate the treatments used
3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Routine care for people with diabetes, with or without obesity, in the hospital setting

Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized at the time of the survey for any cause
* Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
* Age ≥ 18 years
* Written informed consent

Exclusion Criteria

* Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.)
* Paediatric patients (Age \< 18 years)
* Patients without a diabetes diagnosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital de Cascais Dr. José de Almeida (Portugal)

UNKNOWN

Sponsor Role collaborator

Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)

UNKNOWN

Sponsor Role collaborator

Rabin Medical Center

OTHER

Sponsor Role collaborator

Hospital Regional de Malaga

OTHER

Sponsor Role collaborator

Charles University, Czech Republic

OTHER

Sponsor Role collaborator

University Hospital Bratislava

OTHER

Sponsor Role collaborator

Complejo Hospitalario de Especialidades Juan Ramón Jimenez

UNKNOWN

Sponsor Role collaborator

Medical University Innsbruck

OTHER

Sponsor Role collaborator

Aristotle University Of Thessaloniki

OTHER

Sponsor Role collaborator

Rostov State Medical University

UNKNOWN

Sponsor Role collaborator

Hospital Marina Baixa

UNKNOWN

Sponsor Role collaborator

Riga East Clinical University Hospital

OTHER_GOV

Sponsor Role collaborator

University Hospital, Aachen

OTHER

Sponsor Role collaborator

San Raffaele University Hospital, Italy

OTHER

Sponsor Role collaborator

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

Sponsor Role collaborator

Medical University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ann-Kristin Porth

Research Assistant (PhD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandra Kautzky-Willer, Prof

Role: STUDY_DIRECTOR

Medical University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Vienna

Vienna, , Austria

Site Status

General University Hospital in Prague

Prague, , Czechia

Site Status

University Hospital RWTH Aachen

Aachen, , Germany

Site Status

Hippokration General Hospital, Aristotle University of Thessaloniki

Thessaloniki, , Greece

Site Status

Rabin Medical Center, Hasharon Hospital

Petah Tikva, , Israel

Site Status

Riga East Clinical University Hospital

Riga, , Latvia

Site Status

Rostov State Medical University

Rostov-on-Don, , Russia

Site Status

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Czechia Germany Greece Israel Latvia Russia Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 1828/2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.